Max W Sung, MD
- ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
- ASSISTANT PROFESSOR | Oncological Sciences
In the News
Dr. Sung discusses pancreatic cancer in The Daily News feature The Daily Check Up.
View the PDF.
American Board of Internal Medicine
MD, Albert Einstein College of Medicine
Internship, Internal Medicine, Montefiore Medical Center
Residency, Internal Medicine, Montefiore Medical Center
Fellowship, Hematology, Montefiore Medical Center
Fellowship, Neoplastic Diseases, Mount Sinai Hospital
Dr. Sung is currently conducting clinical trials of immunotherapy in patients with advanced colorectal and breast cancers using gene transfer therapy. He is also involved in clinical trials of suicide gene therapy and differentiation therapies for colorectal cancer, and anti-angiogenesis therapy for hepatocellular carcinoma.
Dr. Sung actively participates in multi-modality treatment approaches (surgery/radiation/chemotherapy) to cancers of the liver, colon-rectum, carcinoid, pancreas, esophagus, stomach and anal cancers, and is also experienced in regional treatment modalities such as hepatic arterial chemotherapy/chemoembolization and intraperitoneal chemotherapy.
- A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BLU-554 in Patients with Hepatocellular Carcinoma and Cholangiocarcinoma
The purpose of this study is to obtain information on the safety and tolerability of an experimental drug called BLU-554 when it is given to patients with Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma. Experimental means that it is not yet known if this drug help...
- A Phase 2B, randomized, Controlled, Multicenter, Open-Label Study of the Efficacy and Immune Response of GVAX Pancreas Vaccine (with Cyclophosphamide) and CRS-207 Compared to Chemotherapy or to CRS-207 Alone in Adults with Previously-Treated Metastatic Pancreatic Adenocarcinoma
A vaccine is something that is given to boost a person's immune system to fight or protect against disease. The purpose of this study is to test whether GVAX pancreas vaccine and CRS-207, a weakened form of Listeria bacteria that has been modified to reduce the likelihoo...